| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.097 | 0.004 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.086 | 0.005 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.005 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.097 | 0.005 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.005 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.15 | 0.007 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.088 | 0.007 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.082 | 0.009 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | 0.092 | 0.01 |